Global Glutamate Carboxypeptidase 2 Market Growth 2025-2031

October 2025 | 76 pages | ID: G171D6C9AEB1EN
LP Information

Abstracts

The global Glutamate Carboxypeptidase 2 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Glutamate Carboxypeptidase 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Glutamate Carboxypeptidase 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Glutamate Carboxypeptidase 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Glutamate Carboxypeptidase 2 players cover Cerecor Inc, Crescendo Biologics Ltd, Eisai Co Ltd, Inovio Pharmaceuticals Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Glutamate Carboxypeptidase 2 Industry Forecast? looks at past sales and reviews total world Glutamate Carboxypeptidase 2 sales in 2024, providing a comprehensive analysis by region and market sector of projected Glutamate Carboxypeptidase 2 sales for 2025 through 2031. With Glutamate Carboxypeptidase 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glutamate Carboxypeptidase 2 industry.

This Insight Report provides a comprehensive analysis of the global Glutamate Carboxypeptidase 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glutamate Carboxypeptidase 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Glutamate Carboxypeptidase 2 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glutamate Carboxypeptidase 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glutamate Carboxypeptidase 2.

This report presents a comprehensive overview, market shares, and growth opportunities of Glutamate Carboxypeptidase 2 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• INO-5150
• E-2072
• Others

Segmentation by Application:

• Prostate Cancer
• Neuropathic Pain
• Congnitive Impairment
• Glioblastoma Multiforme
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Cerecor Inc
• Crescendo Biologics Ltd
• Eisai Co Ltd
• Inovio Pharmaceuticals Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glutamate Carboxypeptidase 2 market?
What factors are driving Glutamate Carboxypeptidase 2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glutamate Carboxypeptidase 2 market opportunities vary by end market size?
How does Glutamate Carboxypeptidase 2 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Glutamate Carboxypeptidase 2 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Glutamate Carboxypeptidase 2 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Glutamate Carboxypeptidase 2 by Country/Region, 2020, 2024 & 2031
2.2 Glutamate Carboxypeptidase 2 Segment by Type
  2.2.1 INO-5150
  2.2.2 E-2072
  2.2.3 Others
2.3 Glutamate Carboxypeptidase 2 Sales by Type
  2.3.1 Global Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
  2.3.2 Global Glutamate Carboxypeptidase 2 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Glutamate Carboxypeptidase 2 Sale Price by Type (2020-2025)
2.4 Glutamate Carboxypeptidase 2 Segment by Application
  2.4.1 Prostate Cancer
  2.4.2 Neuropathic Pain
  2.4.3 Congnitive Impairment
  2.4.4 Glioblastoma Multiforme
  2.4.5 Others
2.5 Glutamate Carboxypeptidase 2 Sales by Application
  2.5.1 Global Glutamate Carboxypeptidase 2 Sale Market Share by Application (2020-2025)
  2.5.2 Global Glutamate Carboxypeptidase 2 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Glutamate Carboxypeptidase 2 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Glutamate Carboxypeptidase 2 Breakdown Data by Company
  3.1.1 Global Glutamate Carboxypeptidase 2 Annual Sales by Company (2020-2025)
  3.1.2 Global Glutamate Carboxypeptidase 2 Sales Market Share by Company (2020-2025)
3.2 Global Glutamate Carboxypeptidase 2 Annual Revenue by Company (2020-2025)
  3.2.1 Global Glutamate Carboxypeptidase 2 Revenue by Company (2020-2025)
  3.2.2 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Company (2020-2025)
3.3 Global Glutamate Carboxypeptidase 2 Sale Price by Company
3.4 Key Manufacturers Glutamate Carboxypeptidase 2 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Glutamate Carboxypeptidase 2 Product Location Distribution
  3.4.2 Players Glutamate Carboxypeptidase 2 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLUTAMATE CARBOXYPEPTIDASE 2 BY GEOGRAPHIC REGION

4.1 World Historic Glutamate Carboxypeptidase 2 Market Size by Geographic Region (2020-2025)
  4.1.1 Global Glutamate Carboxypeptidase 2 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Glutamate Carboxypeptidase 2 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glutamate Carboxypeptidase 2 Market Size by Country/Region (2020-2025)
  4.2.1 Global Glutamate Carboxypeptidase 2 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Glutamate Carboxypeptidase 2 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glutamate Carboxypeptidase 2 Sales Growth
4.4 APAC Glutamate Carboxypeptidase 2 Sales Growth
4.5 Europe Glutamate Carboxypeptidase 2 Sales Growth
4.6 Middle East & Africa Glutamate Carboxypeptidase 2 Sales Growth

5 AMERICAS

5.1 Americas Glutamate Carboxypeptidase 2 Sales by Country
  5.1.1 Americas Glutamate Carboxypeptidase 2 Sales by Country (2020-2025)
  5.1.2 Americas Glutamate Carboxypeptidase 2 Revenue by Country (2020-2025)
5.2 Americas Glutamate Carboxypeptidase 2 Sales by Type (2020-2025)
5.3 Americas Glutamate Carboxypeptidase 2 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Glutamate Carboxypeptidase 2 Sales by Region
  6.1.1 APAC Glutamate Carboxypeptidase 2 Sales by Region (2020-2025)
  6.1.2 APAC Glutamate Carboxypeptidase 2 Revenue by Region (2020-2025)
6.2 APAC Glutamate Carboxypeptidase 2 Sales by Type (2020-2025)
6.3 APAC Glutamate Carboxypeptidase 2 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Glutamate Carboxypeptidase 2 by Country
  7.1.1 Europe Glutamate Carboxypeptidase 2 Sales by Country (2020-2025)
  7.1.2 Europe Glutamate Carboxypeptidase 2 Revenue by Country (2020-2025)
7.2 Europe Glutamate Carboxypeptidase 2 Sales by Type (2020-2025)
7.3 Europe Glutamate Carboxypeptidase 2 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Glutamate Carboxypeptidase 2 by Country
  8.1.1 Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Glutamate Carboxypeptidase 2 Revenue by Country (2020-2025)
8.2 Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Type (2020-2025)
8.3 Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glutamate Carboxypeptidase 2
10.3 Manufacturing Process Analysis of Glutamate Carboxypeptidase 2
10.4 Industry Chain Structure of Glutamate Carboxypeptidase 2

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Glutamate Carboxypeptidase 2 Distributors
11.3 Glutamate Carboxypeptidase 2 Customer

12 WORLD FORECAST REVIEW FOR GLUTAMATE CARBOXYPEPTIDASE 2 BY GEOGRAPHIC REGION

12.1 Global Glutamate Carboxypeptidase 2 Market Size Forecast by Region
  12.1.1 Global Glutamate Carboxypeptidase 2 Forecast by Region (2026-2031)
  12.1.2 Global Glutamate Carboxypeptidase 2 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glutamate Carboxypeptidase 2 Forecast by Type (2026-2031)
12.7 Global Glutamate Carboxypeptidase 2 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Cerecor Inc
  13.1.1 Cerecor Inc Company Information
  13.1.2 Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
  13.1.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Cerecor Inc Main Business Overview
  13.1.5 Cerecor Inc Latest Developments
13.2 Crescendo Biologics Ltd
  13.2.1 Crescendo Biologics Ltd Company Information
  13.2.2 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
  13.2.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Crescendo Biologics Ltd Main Business Overview
  13.2.5 Crescendo Biologics Ltd Latest Developments
13.3 Eisai Co Ltd
  13.3.1 Eisai Co Ltd Company Information
  13.3.2 Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
  13.3.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eisai Co Ltd Main Business Overview
  13.3.5 Eisai Co Ltd Latest Developments
13.4 Inovio Pharmaceuticals Inc
  13.4.1 Inovio Pharmaceuticals Inc Company Information
  13.4.2 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
  13.4.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Inovio Pharmaceuticals Inc Main Business Overview
  13.4.5 Inovio Pharmaceuticals Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Glutamate Carboxypeptidase 2 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Glutamate Carboxypeptidase 2 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of INO-5150
Table 4. Major Players of E-2072
Table 5. Major Players of Others
Table 6. Global Glutamate Carboxypeptidase 2 Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
Table 8. Global Glutamate Carboxypeptidase 2 Revenue by Type (2020-2025) & ($ million)
Table 9. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Type (2020-2025)
Table 10. Global Glutamate Carboxypeptidase 2 Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Glutamate Carboxypeptidase 2 Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Glutamate Carboxypeptidase 2 Sale Market Share by Application (2020-2025)
Table 13. Global Glutamate Carboxypeptidase 2 Revenue by Application (2020-2025) & ($ million)
Table 14. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Application (2020-2025)
Table 15. Global Glutamate Carboxypeptidase 2 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Glutamate Carboxypeptidase 2 Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Glutamate Carboxypeptidase 2 Sales Market Share by Company (2020-2025)
Table 18. Global Glutamate Carboxypeptidase 2 Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Company (2020-2025)
Table 20. Global Glutamate Carboxypeptidase 2 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Glutamate Carboxypeptidase 2 Producing Area Distribution and Sales Area
Table 22. Players Glutamate Carboxypeptidase 2 Products Offered
Table 23. Glutamate Carboxypeptidase 2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Glutamate Carboxypeptidase 2 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Glutamate Carboxypeptidase 2 Sales Market Share Geographic Region (2020-2025)
Table 28. Global Glutamate Carboxypeptidase 2 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Glutamate Carboxypeptidase 2 Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Glutamate Carboxypeptidase 2 Sales Market Share by Country/Region (2020-2025)
Table 32. Global Glutamate Carboxypeptidase 2 Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Glutamate Carboxypeptidase 2 Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Glutamate Carboxypeptidase 2 Sales Market Share by Country (2020-2025)
Table 36. Americas Glutamate Carboxypeptidase 2 Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Glutamate Carboxypeptidase 2 Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Glutamate Carboxypeptidase 2 Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Glutamate Carboxypeptidase 2 Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Glutamate Carboxypeptidase 2 Sales Market Share by Region (2020-2025)
Table 41. APAC Glutamate Carboxypeptidase 2 Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Glutamate Carboxypeptidase 2 Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Glutamate Carboxypeptidase 2 Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Glutamate Carboxypeptidase 2 Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Glutamate Carboxypeptidase 2 Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Glutamate Carboxypeptidase 2 Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Glutamate Carboxypeptidase 2 Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Glutamate Carboxypeptidase 2 Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Glutamate Carboxypeptidase 2 Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Glutamate Carboxypeptidase 2
Table 53. Key Market Challenges & Risks of Glutamate Carboxypeptidase 2
Table 54. Key Industry Trends of Glutamate Carboxypeptidase 2
Table 55. Glutamate Carboxypeptidase 2 Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Glutamate Carboxypeptidase 2 Distributors List
Table 58. Glutamate Carboxypeptidase 2 Customer List
Table 59. Global Glutamate Carboxypeptidase 2 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Glutamate Carboxypeptidase 2 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Glutamate Carboxypeptidase 2 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Glutamate Carboxypeptidase 2 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Glutamate Carboxypeptidase 2 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Glutamate Carboxypeptidase 2 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Glutamate Carboxypeptidase 2 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Glutamate Carboxypeptidase 2 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Glutamate Carboxypeptidase 2 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Glutamate Carboxypeptidase 2 Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Glutamate Carboxypeptidase 2 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Glutamate Carboxypeptidase 2 Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Glutamate Carboxypeptidase 2 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Cerecor Inc Basic Information, Glutamate Carboxypeptidase 2 Manufacturing Base, Sales Area and Its Competitors
Table 74. Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
Table 75. Cerecor Inc Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Cerecor Inc Main Business
Table 77. Cerecor Inc Latest Developments
Table 78. Crescendo Biologics Ltd Basic Information, Glutamate Carboxypeptidase 2 Manufacturing Base, Sales Area and Its Competitors
Table 79. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
Table 80. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Crescendo Biologics Ltd Main Business
Table 82. Crescendo Biologics Ltd Latest Developments
Table 83. Eisai Co Ltd Basic Information, Glutamate Carboxypeptidase 2 Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
Table 85. Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Eisai Co Ltd Main Business
Table 87. Eisai Co Ltd Latest Developments
Table 88. Inovio Pharmaceuticals Inc Basic Information, Glutamate Carboxypeptidase 2 Manufacturing Base, Sales Area and Its Competitors
Table 89. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolios and Specifications
Table 90. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Inovio Pharmaceuticals Inc Main Business
Table 92. Inovio Pharmaceuticals Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Glutamate Carboxypeptidase 2
Figure 2. Glutamate Carboxypeptidase 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glutamate Carboxypeptidase 2 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Glutamate Carboxypeptidase 2 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Glutamate Carboxypeptidase 2 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Glutamate Carboxypeptidase 2 Sales Market Share by Country/Region (2024)
Figure 10. Glutamate Carboxypeptidase 2 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of INO-5150
Figure 12. Product Picture of E-2072
Figure 13. Product Picture of Others
Figure 14. Global Glutamate Carboxypeptidase 2 Sales Market Share by Type in 2025
Figure 15. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Type (2020-2025)
Figure 16. Glutamate Carboxypeptidase 2 Consumed in Prostate Cancer
Figure 17. Global Glutamate Carboxypeptidase 2 Market: Prostate Cancer (2020-2025) & (K Pcs)
Figure 18. Glutamate Carboxypeptidase 2 Consumed in Neuropathic Pain
Figure 19. Global Glutamate Carboxypeptidase 2 Market: Neuropathic Pain (2020-2025) & (K Pcs)
Figure 20. Glutamate Carboxypeptidase 2 Consumed in Congnitive Impairment
Figure 21. Global Glutamate Carboxypeptidase 2 Market: Congnitive Impairment (2020-2025) & (K Pcs)
Figure 22. Glutamate Carboxypeptidase 2 Consumed in Glioblastoma Multiforme
Figure 23. Global Glutamate Carboxypeptidase 2 Market: Glioblastoma Multiforme (2020-2025) & (K Pcs)
Figure 24. Glutamate Carboxypeptidase 2 Consumed in Others
Figure 25. Global Glutamate Carboxypeptidase 2 Market: Others (2020-2025) & (K Pcs)
Figure 26. Global Glutamate Carboxypeptidase 2 Sale Market Share by Application (2024)
Figure 27. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Application in 2025
Figure 28. Glutamate Carboxypeptidase 2 Sales by Company in 2025 (K Pcs)
Figure 29. Global Glutamate Carboxypeptidase 2 Sales Market Share by Company in 2025
Figure 30. Glutamate Carboxypeptidase 2 Revenue by Company in 2025 ($ millions)
Figure 31. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Company in 2025
Figure 32. Global Glutamate Carboxypeptidase 2 Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Glutamate Carboxypeptidase 2 Sales 2020-2025 (K Pcs)
Figure 35. Americas Glutamate Carboxypeptidase 2 Revenue 2020-2025 ($ millions)
Figure 36. APAC Glutamate Carboxypeptidase 2 Sales 2020-2025 (K Pcs)
Figure 37. APAC Glutamate Carboxypeptidase 2 Revenue 2020-2025 ($ millions)
Figure 38. Europe Glutamate Carboxypeptidase 2 Sales 2020-2025 (K Pcs)
Figure 39. Europe Glutamate Carboxypeptidase 2 Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Glutamate Carboxypeptidase 2 Sales 2020-2025 (K Pcs)
Figure 41. Middle East & Africa Glutamate Carboxypeptidase 2 Revenue 2020-2025 ($ millions)
Figure 42. Americas Glutamate Carboxypeptidase 2 Sales Market Share by Country in 2025
Figure 43. Americas Glutamate Carboxypeptidase 2 Revenue Market Share by Country (2020-2025)
Figure 44. Americas Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
Figure 45. Americas Glutamate Carboxypeptidase 2 Sales Market Share by Application (2020-2025)
Figure 46. United States Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Glutamate Carboxypeptidase 2 Sales Market Share by Region in 2025
Figure 51. APAC Glutamate Carboxypeptidase 2 Revenue Market Share by Region (2020-2025)
Figure 52. APAC Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
Figure 53. APAC Glutamate Carboxypeptidase 2 Sales Market Share by Application (2020-2025)
Figure 54. China Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 58. India Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Glutamate Carboxypeptidase 2 Sales Market Share by Country in 2025
Figure 62. Europe Glutamate Carboxypeptidase 2 Revenue Market Share by Country (2020-2025)
Figure 63. Europe Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
Figure 64. Europe Glutamate Carboxypeptidase 2 Sales Market Share by Application (2020-2025)
Figure 65. Germany Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 66. France Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Market Share by Application (2020-2025)
Figure 73. Egypt Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Glutamate Carboxypeptidase 2 Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Glutamate Carboxypeptidase 2 in 2025
Figure 79. Manufacturing Process Analysis of Glutamate Carboxypeptidase 2
Figure 80. Industry Chain Structure of Glutamate Carboxypeptidase 2
Figure 81. Channels of Distribution
Figure 82. Global Glutamate Carboxypeptidase 2 Sales Market Forecast by Region (2026-2031)
Figure 83. Global Glutamate Carboxypeptidase 2 Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Glutamate Carboxypeptidase 2 Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Glutamate Carboxypeptidase 2 Revenue Market Share Forecast by Application (2026-2031)